Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Molecular Profile | CD274 positive |
Therapy | Camrelizumab |
Indication/Tumor Type | cervical adenocarcinoma |
Response Type | predicted - sensitive |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
CD274 positive | cervical adenocarcinoma | predicted - sensitive | Camrelizumab | Case Reports/Case Series | Actionable | In a clinical case study, Camrelizumab (SHR-1210) treatment resulted in a partial response in the cervical tumor and a complete response in the pulmonary metastases in a patient with CD274 (PD-L1)-positive (IHC = 1%) cervical adenocarcinoma, who previously progressed on chemotherapy treatment (PMID: 35280424). | 35280424 |
PubMed Id | Reference Title | Details |
---|---|---|
(35280424) | Camrelizumab for the treatment of advanced cervical adenocarcinoma: a case report and literature review. | Full reference... |